Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231872 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 11 Pages |
Abstract
According to our data, the level of PrxI combined with the p53 status is relevant to the prognosis and the treatment response. We suggested that PrxI might be a new biomarker for rectal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Miao-Fen M.D., Ph.D., Kuan-Der M.D., Ph.D., Chung-Hung M.D., Wen-Cheng M.D., Wen-Shih Huang, Chih-Chien M.D., Paul- Yang M.D., Jeng-Yi M.D.,